BeOne Medicines (ONC) Operating Margin: 2015-2025
Historic Operating Margin for BeOne Medicines (ONC) over the last 10 years, with Sep 2025 value amounting to 11.55%.
- BeOne Medicines' Operating Margin rose 2356.00% to 11.55% in Q3 2025 from the same period last year, while for Sep 2025 it was 3.67%, marking a year-over-year increase of 2998.00%. This contributed to the annual value of -14.91% for FY2024, which is 3421.00% up from last year.
- Latest data reveals that BeOne Medicines reported Operating Margin of 11.55% as of Q3 2025, which was up 72.85% from 6.68% recorded in Q2 2025.
- BeOne Medicines' Operating Margin's 5-year high stood at 89.06% during Q4 2021, with a 5-year trough of -316.58% in Q2 2021.
- In the last 3 years, BeOne Medicines' Operating Margin had a median value of -12.01% in 2024 and averaged -23.66%.
- In the last 5 years, BeOne Medicines' Operating Margin soared by 72,953bps in 2021 and then tumbled by 21,235bps in 2022.
- Over the past 5 years, BeOne Medicines' Operating Margin (Quarterly) stood at 89.06% in 2021, then crashed by 21,235bps to -123.29% in 2022, then spiked by 6,279bps to -60.50% in 2023, then spiked by 5,345bps to -7.04% in 2024, then soared by 2,356bps to 11.55% in 2025.
- Its Operating Margin was 11.55% in Q3 2025, compared to 6.68% in Q2 2025 and 0.99% in Q1 2025.